LOGIN
Research
Research
Published CBD Research Articles
An Introduction to the Endogenous Cannabinoid System
Courtesy of the U.S. National Library of Medicine
Dermal and transdermal drug delivery systems: current and future prospects
Courtesy of the U.S. National Library of Medicine
Skin penetration and tissue permeation after topical administration of diclofenac
Courtesy of the U.S. National Library of Medicine
Evaluation of the cyclooxygenase inhibiting effects of six major cannabinoids isolated from Cannabis sativa
Courtesy of the U.S. National Library of Medicine
Cannabinoid-based drugs as anti-inflammatory therapeutics.
Courtesy of the U.S. National Library of Medicine
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Courtesy of the U.S. National Library of Medicine
In this country, the sale of CBD products is expected to hit $4.75 billion in 2020, up 14% from last year. Within the professional marketplace there are essentially no CBD products that doctors can provide to patients at their practice. There are products for consumers that may address a related issue, but it is the responsibility of the consumer to make the decision to purchase the product and office staff are not involved in the process.
Transdermal Relief Cream (TRC™) contains a higher concentration of CBD (2.5% transdermal cannabidiol) than those available at over-the-counter retail locations. It is a topical cream that is massaged on the skin in the area of discomfort that acts quickly and provides temporary, long-lasting relief.
Our groundbreaking CBD product is an exciting new treatment for discomfort. Learn about CBD as it’s used in the medical industry today, where it’s headed, and how we at Holistic Health Therapeutics harnessed the power of CBD to create TRC™.
